When analyzing patients according to breast cancer subtypes, we found that Wnt-5a was a robust prognostic marker for luminal A tumors (p = 0.04; n = 161) but not for luminal B, HER2+ or triple-negative tumors (Figure 2). Here, ERBB2 is linked to breast cancer.